Type 2 Diabetes Mellitus Modifies the Prognostic Value of LDL Particle Size in Statin‐treated Patients With Coronary Artery Disease: A Large‐scale Cohort Study
Xiaohui Bian, Jining He, Chenxi Song, Rui Zhang, Sheng Yuan, Guofeng Gao, Kefei Dou · 2026
Read Type 2 Diabetes Mellitus Modifies the Prognostic Value of LDL Particle Size in Statin‐treated Patients With Coronary Artery Disease: A Large‐scale Cohort Study by Xiaohui Bian, Jining He, Chenxi Song, Rui Zhang, Sheng Yuan, Guofeng Gao, Kefei Dou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13507696.txt.
Description
Xiaohui Bian and co-authors published this study in 2026. It asks whether diabetes changes what LDL particle size foretells in heart patients. The team followed over twenty-one thousand people with coronary artery disease, all on statin drugs. Particle size was gauged by a simple ratio of two blood measures. The main outcome bundled death, heart attack, and repeat vessel work over about three years.
Higher ratios, meaning larger particles, linked to fewer events, but only in patients with diabetes. Each small step up in the ratio came with about a five percent risk drop in that group. Without diabetes, no clear link appeared. Plain cholesterol and particle-count measures showed no such link in the diabetes group. The authors say the ratio may flag leftover risk better than standard cholesterol in these patients.
Catalog record
| CREATOR | Xiaohui Bian, Jining He, Chenxi Song, Rui Zhang, Sheng Yuan, Guofeng Gao, Kefei Dou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |